Advanced search
Publication Cover
Climacteric Volume 8, 2005 - Issue 1
Submit an article Journal homepage
485
Views
129
CrossRef citations to date
0
Altmetric
Original Article

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet

E Weisberg Research Division of FPA Health, Sydney Centre for Reproductive Health Research
,
R Ayton Royal Women's Hospital, Melbourne
,
G Darling Royal Women's Hospital, Melbourne
,
E Farrell Monash Medical Centre, Melbourne
,
A Murkies Monash Medical Centre, Melbourne
,
S O'Neill Lilian Cooper Centre, Spring Hill, Queensland
,
Y Kirkegard Lilian Cooper Centre, Spring Hill, Queensland
&
IS Fraser Research Division of FPA Health, Sydney Centre for Reproductive Health Research; Department of Obstetrics and Gynaecology, University of Sydney, Australia
 show all
Pages 83-93 | Received 11 Jun 2004, Accepted 29 Sep 2004, Published online: 03 Jul 2009

Citations (129)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (24)

M. Shapiro. (2019) What should guide our patient management of vulvovaginal atrophy?. Climacteric 22:1, pages 38-43.
Read now
N. Bruyniks, N. Biglia, S. Palacios & A. O. Mueck. (2017) Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy. Climacteric 20:3, pages 195-204.
Read now
J. H. Pickar, J. M. Amadio, B. A. Bernick & S. Mirkin. (2016) Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule. Climacteric 19:2, pages 181-187.
Read now
T. Tzur, D. Yohai & A. Y. Weintraub. (2016) The role of local estrogen therapy in the management of pelvic floor disorders. Climacteric 19:2, pages 162-171.
Read now
J. Calleja-Agius & M. P. Brincat. (2015) The urogenital system and the menopause. Climacteric 18:sup1, pages 18-22.
Read now
P. Stute, T. W. May, C. Masur & I. M. Schmidts-Winkler. (2015) Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial. Climacteric 18:4, pages 582-589.
Read now
R. J. Santen. (2015) Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels. Climacteric 18:2, pages 121-134.
Read now
Sarah H Lindahl. (2014) Reviewing the options for local estrogen treatment of vaginal atrophy. International Journal of Women's Health 6, pages 307-312.
Read now
Suzanne Reiter. (2013) Barriers to effective treatment of vaginal atrophy with local estrogen therapy. International Journal of General Medicine 6, pages 153-158.
Read now
Luciano Mariani, Angiolo Gadducci, Enrico Vizza, Silverio Tomao & Patrizia Vici. (2013) Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy. Gynecological Endocrinology 29:1, pages 25-29.
Read now
Lisa A Chism. (2012) Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy. International Journal of Women's Health 4, pages 551-557.
Read now
Lino Del Pup. (2012) Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients. Gynecological Endocrinology 28:9, pages 740-745.
Read now
R. E. Nappi & S. R. Davis. (2012) The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Climacteric 15:3, pages 267-274.
Read now
D. W. Sturdee & N. Panay. (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:6, pages 509-522.
Read now
L. S. G. Ulrich, T. Naessen, D. Elia, J. A. Goldstein & M. Eugster-Hausmann. (2010) Endometrial safety of ultra-low-dose Vagifem 10 μg in postmenopausal women with vaginal atrophy. Climacteric 13:3, pages 228-237.
Read now
Nicoletta Biglia, Elisa Peano, Paola Sgandurra, Giulia Moggio, Enrico Panuccio, Marco Migliardi, Nicoletta Ravarino, Riccardo Ponzone & Piero Sismondi. (2010) Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecological Endocrinology 26:6, pages 404-412.
Read now
SA Kingsberg, S Kellogg & M Krychman. (2009) Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy. International Journal of Women's Health 1, pages 105-111.
Read now
R. E. Nappi, F. Albani, L. Chiovato & F. Polatti. (2009) Local estrogens for quality of life and sexuality in postmenopausal women with cardiovascular disease. Climacteric 12:sup1, pages 112-116.
Read now
J. Calleja-Agius & M. P. Brincat. (2009) Urogenital atrophy. Climacteric 12:4, pages 279-285.
Read now
O. Al-Baghdadi & A. A. A. Ewies. (2009) Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 12:2, pages 91-105.
Read now
Camil Castelo-Branco & María Jesús Cancelo. (2008) Compounds for the treatment of atropic vaginitis. Expert Opinion on Therapeutic Patents 18:12, pages 1385-1394.
Read now
Ian S Fraser & Diana Mansour. (2006) Delivery systems for hormone replacement therapy. Expert Opinion on Drug Delivery 3:2, pages 191-204.
Read now
Alastair H. MacLennan & David W. Sturdee. (2006) Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?. Climacteric 9:5, pages 321-322.
Read now
. (2005) Book of Abstracts. Climacteric 8:sup2, pages 1-246.
Read now

Articles from other publishers (105)

James A. Simon, Alex Ferenczy, Denise Black, Alex Castonguay, Catherine Royer, Rafik Marouf & Catherine Beauchemin. (2023) Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis. Menopause 30:8, pages 855-866.
Crossref
Frank Z. Stanczyk, Rachel S. Mandelbaum, Harpreet Matharu, Christina E. Dancz & Mark E. Sherman. (2023) Endometrial safety of low-dose vaginal estrogens. Menopause 30:6, pages 650-658.
Crossref
Ahmed Abdelgader, Mershen Govender, Pradeep Kumar & Yahya E. Choonara. (2023) Intravaginal Drug Delivery Systems to Treat the Genitourinary Syndrome of Menopause: Towards the Design of Safe and Efficacious Estrogen-loaded Prototypes. Journal of Pharmaceutical Sciences 112:6, pages 1566-1585.
Crossref
Hiroaki Ohta, Mariko Hatta, Kuniaki Ota, Remi Yoshikata & Stefano Salvatore. (2023) An online survey on coping methods for genitourinary syndrome of menopause, including vulvovaginal atrophy, among Japanese women and their satisfaction levels. BMC Women's Health 23:1.
Crossref
Louise Hull, Bronwyn G. A. Stuckey, Kimberly Hartman, Nadene Zack & David R. Friend. (2023) Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study. Menopause 30:4, pages 427-436.
Crossref
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin e1 e39 .
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin 19 58 .
Louie Ye, Benita Knox & Martha Hickey. (2022) Management of Menopause Symptoms and Quality of Life during the Menopause Transition. Endocrinology and Metabolism Clinics of North America 51:4, pages 817-836.
Crossref
Kathleen Ridgeway, Elizabeth T. Montgomery, Kevin Smith, Kristine Torjesen, Ariane van der Straten, Sharon L. Achilles & Jennifer B. Griffin. (2022) Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception 106, pages 16-33.
Crossref
. (2020) The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 27:9, pages 976-992.
Crossref
Peng Teng & Min Hao. (2020) A population‐based study of age‐related associations between vaginal pH and the development of cervical intraepithelial neoplasia. Cancer Medicine 9:5, pages 1890-1902.
Crossref
Carolyn J. Crandall, Allison Diamant & Nanette Santoro. (2020) Safety of vaginal estrogens: a systematic review. Menopause 27:3, pages 339-360.
Crossref
Richard J. Santen, Sebastian Mirkin, Brian Bernick & Ginger D. Constantine. (2020) Systemic estradiol levels with low-dose vaginal estrogens. Menopause 27:3, pages 361-370.
Crossref
Ginger D. Constantine, Shelli Graham, Kate Lapane, Kathleen Ohleth, Brian Bernick, James Liu & Sebastian Mirkin. (2019) Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review. Menopause 26:7, pages 800-807.
Crossref
Shilpa N. Bhupathiraju, Francine Grodstein, Meir J. Stampfer, Walter C. Willett, Carolyn J. Crandall, Jan L. Shifren & JoAnn E. Manson. (2019) Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study. Menopause 26:6, pages 603-610.
Crossref
Colton Biehl, Olivia Plotsker & Sebastian Mirkin. (2019) A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause 26:4, pages 431-453.
Crossref
Vincenzina Bruni & Francesca Pampaloni. 2019. Menstrual Cycle Related Disorders. Menstrual Cycle Related Disorders 111 142 .
Susan J. Diem, Katherine A. Guthrie, Caroline M. Mitchell, Susan D. Reed, Joseph C. Larson, Kristine E. Ensrud & Andrea Z. LaCroix. (2018) Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Menopause 25:10, pages 1086-1093.
Crossref
Clare F. McCoy, David C. Apperley, Bruce Variano, Heather Sussman, Daniel Loeven, Peter Boyd & R. Karl Malcolm. (2018) Solid state 13C NMR spectroscopy provides direct evidence for reaction between ethinyl estradiol and a silicone elastomer vaginal ring drug delivery system. International Journal of Pharmaceutics 548:1, pages 689-697.
Crossref
Kate M. Guthrie, Rochelle K. Rosen, Sara E. Vargas, Melissa L. Getz, Lauren Dawson, Melissa Guillen, Jaime J. Ramirez, Marc M. Baum & Kathleen L. Vincent. (2018) User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences. PLOS ONE 13:5, pages e0197269.
Crossref
Cynthia A. Stuenkel. (2018) More evidence why the product labeling for low-dose vaginal estrogen should be changed?. Menopause 25:1, pages 4-6.
Crossref
JoAnn V. Pinkerton, Andrew M. Kaunitz & JoAnn E. Manson. (2017) Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance. Menopause 24:12, pages 1329-1332.
Crossref
B. Tamarelle, K. Charvier, L. Badet, J.-E. Terrier, P. Grise, G. Mellier, F. Golfier & A. Ruffion. (2017) Avis d’experts sur les modalités et limites de prescription des estrogènes locaux dans l’incontinence urinaire chez la femme. Progrès en Urologie 27:11, pages 585-593.
Crossref
Christine Hong, Dayoung SongDong-Keun LeeLawrence Lin, Hsin Chuan PanDeborah LeePeng DengZhenqing LiuDanny HadayaHye-Lim LeeAbdulaziz MohammadXinli ZhangMin LeeCun-Yu WangDean Ho. (2017) Reducing posttreatment relapse in cleft lip palatal expansion using an injectable estrogen–nanodiamond hydrogel. Proceedings of the National Academy of Sciences 114:35.
Crossref
Michelle E. Melisko, Mindy E. Goldman, Jimmy Hwang, Amy De Luca, Sally Fang, Laura J. Esserman, Amy J. Chien, John W. Park & Hope S. Rugo. (2017) Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer. JAMA Oncology 3:3, pages 313.
Crossref
Fernand Labrie & Céline Martel. (2017) A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values. Hormone Molecular Biology and Clinical Investigation 29:2, pages 39-60.
Crossref
Meena Dayal & Preeti Yadav. (2017) Management of Postmenopausal Vaginal Atrophy: Review of Literature. Journal of SAFOMS 5:1, pages 51-57.
Crossref
Paul R. Summers. 2017. Textbook of Aging Skin. Textbook of Aging Skin 435 441 .
Julia V. Johnson. 2016. Office Care of Women. Office Care of Women 341 348 .
. 2016. Office Care of Women. Office Care of Women 285 366 .
James H. Pickar, Julia M. Amadio, John M. Hill, Brian A. Bernick & Sebastian Mirkin. (2016) A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol. Menopause 23:5, pages 506-510.
Crossref
Yuyong Ke, Renaud Gonthier, Jean-Nicolas Simard, David Archer, Lyne Lavoie, Céline Martel, Mario Vaillancourt & Fernand Labrie. (2015) Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA. Hormone Molecular Biology and Clinical Investigation 24:3, pages 117-129.
Crossref
Santiago Palacios, Laura Baquedano, Jackie Calleja & Mariela Fernández. (2015) Tratamiento de la atrofia vaginal a través de anillo con liberación de ultrabaja dosis de estradiol. Progresos de Obstetricia y Ginecología 58:8, pages 381-387.
Crossref
M. A. Weber, M. H. Kleijn, M. Langendam, J. Limpens, M. J. Heineman & J. P. Roovers. (2015) Local Oestrogen for Pelvic Floor Disorders: A Systematic Review. PLOS ONE 10:9, pages e0136265.
Crossref
David F. Archer. (2015) Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy. The Journal of Steroid Biochemistry and Molecular Biology 145, pages 139-143.
Crossref
M. A. Weber, J. Limpens & J. P. W. R. Roovers. (2014) Assessment of vaginal atrophy: a review. International Urogynecology Journal 26:1, pages 15-28.
Crossref
Paul R. Summers. 2014. Textbook of Aging Skin. Textbook of Aging Skin 1 7 .
David D. Rahn, Cassandra Carberry, Tatiana V. Sanses, Mamta M. Mamik, Renée M. Ward, Kate V. Meriwether, Cedric K. Olivera, Husam Abed, Ethan M. Balk & Miles Murphy. (2014) Vaginal Estrogen for Genitourinary Syndrome of Menopause. Obstetrics & Gynecology 124:6, pages 1147-1156.
Crossref
Meghan E. Pratts & Wen Shen. (2014) Complication of a 2-mg estradiol vaginal ring. Menopause 21:11, pages 1254-1256.
Crossref
JoAnn E. Manson, Steven R. Goldstein, Risa Kagan, Andrew M. Kaunitz, James H. Liu, JoAnn V. Pinkerton, Robert W. Rebar, Peter F. Schnatz, Jan L. Shifren, Cynthia A. Stuenkel, Margery L.S. Gass & Wulf H. Utian. (2014) Why the product labeling for low-dose vaginal estrogen should be changed. Menopause 21:9, pages 911-916.
Crossref
Sônia Maria Rolim Rosa Lima, Bianca Franco Augusto Bernardo, Silvia Saito Yamada, Benedito Fabiano Reis, Gustavo Maximiliano Dutra da Silva & Maria Antonieta Longo Galvão. (2014) Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled trial. Maturitas 78:3, pages 205-211.
Crossref
David Sturdee. (2014) Urogenital atrophy. Post Reproductive Health 20:2, pages 73-75.
Crossref
Irwin Goldstein, Brian Dicks, Noel N. Kim & Rose Hartzell. (2013) Multidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal Women. Sexual Medicine 1:2, pages 44-53.
Crossref
Sandy J. Falk & Don S. Dizon. (2013) Sexual dysfunction in women with cancer. Fertility and Sterility 100:4, pages 916-921.
Crossref
. (2013) Management of symptomatic vulvovaginal atrophy. Menopause 20:9, pages 888-902.
Crossref
Surveen Ghumman. (2013) Atrophic Vaginitis: Diagnosis and Treatment. Journal of SAFOMS 1:1, pages 4-12.
Crossref
S. Buchholz & O. Ortmann. (2013) Behandlung von klimakterischen Symptomen bei Frauen mit gyn?kologischen Malignomen und MammakarzinomTreatment of climacteric symptoms in women with gynecological malignancies and breast cancer. Der Gyn?kologe 46:3, pages 160-164.
Crossref
Juliane Baumgart, Kerstin Nilsson, Anneli Stavreus Evers, Theodora Kunovac Kallak & Inger Sundström Poromaa. (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 20:2, pages 162-168.
Crossref
Alfred O. Mueck. 2013. Therapiehandbuch Gynäkologie und Geburtshilfe. Therapiehandbuch Gynäkologie und Geburtshilfe 281 312 .
H.-J. Ahrendt & C. Friedrich. 2013. Die Gynäkologie. Die Gynäkologie 1069 1082 .
Megan A Clarke, Ana Cecilia Rodriguez, Julia C Gage, Rolando Herrero, Allan Hildesheim, Sholom Wacholder, Robert Burk & Mark Schiffman. (2012) A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infectious Diseases 12:1.
Crossref
Nancy Fugate Woods. (2012) An Overview of Chronic Vaginal Atrophy and Options for Symptom Management. Nursing for Women's Health 16:6, pages 482-494.
Crossref
June D Cody, Madeleine Louisa Jacobs, Karen Richardson, Birgit Moehrer & Andrew Hextall. (2012) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database of Systematic Reviews.
Crossref
Shannon Wills, Anita Ravipati, Padmaja Venuturumilli, Cynthia Kresge, Elizabeth Folkerd, Mitch Dowsett, Daniel F. Hayes & David A. Decker. (2012) Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor Modulator. Journal of Oncology Practice 8:3, pages 144-148.
Crossref
M. Moegele, S. Buchholz, S. Seitz, C. Lattrich & O. Ortmann. (2012) Vaginale Östrogentherapie bei MammakarzinompatientinnenVaginal estrogen therapy in breast cancer patients. Gynäkologische Endokrinologie 10:1, pages 57-60.
Crossref
James A. Simon. (2011) Identifying and Treating Sexual Dysfunction in Postmenopausal Women: The Role of Estrogen. Journal of Women's Health 20:10, pages 1453-1465.
Crossref
Rebecca S. Nelken, Begüm Z. Özel, Ava R. Leegant, Juan C. Felix & Daniel R. Mishell. (2011) Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder. Menopause 18:9, pages 962-966.
Crossref
Mary Panjari & Susan R. Davis. (2011) Vaginal DHEA to treat menopause related atrophy: A review of the evidence. Maturitas 70:1, pages 22-25.
Crossref
Judy King, Catherine Harper Wynne, Laura Assersohn & Alison Jones. (2011) Hormone replacement therapy and women with premature menopause – A cancer survivorship issue. European Journal of Cancer 47:11, pages 1623-1632.
Crossref
Michael L. Krychman. (2011) Vaginal Estrogens for the Treatment of Dyspareunia. The Journal of Sexual Medicine 8:3, pages 666-674.
Crossref
Iara M. Linhares, Paul R. Summers, Bryan Larsen, Paulo C. Giraldo & Steven S. Witkin. (2011) Contemporary perspectives on vaginal pH and lactobacilli. American Journal of Obstetrics and Gynecology 204:2, pages 120.e1-120.e5.
Crossref
Juliane Baumgart, Kerstin Nilsson, Anneli Stavreus-Evers, Kristiina Kask, Kenneth Villman, Henrik Lindman, Theodora Kallak & Inger Sundström-Poromaa. (2011) Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. American Journal of Obstetrics and Gynecology 204:1, pages 26.e1-26.e7.
Crossref
Mary Beth Dorr, Anita L. Nelson, Philip R. Mayer, Radhika P. Ranganath, Paul M. Norris, Eileen C. Helzner & Richard A. Preston. (2010) Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis. Fertility and Sterility 94:6, pages 2365-2368.
Crossref
Colleen L. Milroy & Kirtly Parker Jones. (2010) Gynecologic Care in Hematopoietic Stem Cell Transplant Patients: A Review. Obstetrical & Gynecological Survey 65:10, pages 668-679.
Crossref
Catherine S. Stika. (2010) Atrophic vaginitis. Dermatologic Therapy 23:5, pages 514-522.
Crossref
Michelle E. Melisko, Mindy Goldman & Hope S. Rugo. (2010) Amelioration of sexual adverse effects in the early breast cancer patient. Journal of Cancer Survivorship 4:3, pages 247-255.
Crossref
JoAnn V. Pinkerton & Dale W. Stovall. (2010) Reproductive aging, menopause, and health outcomes. Annals of the New York Academy of Sciences 1204:1, pages 169-178.
Crossref
Timothy Hillard. (2010) The postmenopausal bladder. Menopause International 16:2, pages 74-80.
Crossref
Jan L. Shifren & Isaac Schiff. (2010) Role of Hormone Therapy in the Management of Menopause. Obstetrics & Gynecology 115:4, pages 839-855.
Crossref
Irwin Goldstein. (2010) Recognizing and Treating Urogenital Atrophy in Postmenopausal Women. Journal of Women's Health 19:3, pages 425-432.
Crossref
Gerald W. Smetana & Jane S. Sillman. (2009) Update in New Medications for Primary Care. Journal of General Internal Medicine 25:3, pages 261-269.
Crossref
David F. Archer. (2010) Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 17:1, pages 194-203.
Crossref
Paul R. Summers. 2010. Textbook of Aging Skin. Textbook of Aging Skin 247 251 .
Janet A. Chollet, Gloria Carter, Leslie A. Meyn, Fred Mermelstein & Judith L. Balk. (2009) Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause 16:5, pages 978-983.
Crossref
Fernand Labrie, David Archer, Céline Bouchard, Michel Fortier, Leonello Cusan, José-Luis Gomez, Ginette Girard, Mira Baron, Normand Ayotte, Michèle Moreau, Robert Dubé, Isabelle Côté, Claude Labrie, Lyne Lavoie, Louise Berger, Lucy Gilbert, Céline Martel & John Balser. (2009) Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 16:5, pages 907-922.
Crossref
Fernand Labrie, David Archer, Céline Bouchard, Michel Fortier, Leonello Cusan, José-Luis Gomez, Ginette Girard, Mira Baron, Normand Ayotte, Michèle Moreau, Robert Dubé, Isabelle Côté, Claude Labrie, Lyne Lavoie, René Bérubé, Patrick Bélanger, Louise Berger, Lucy Gilbert, Céline Martel & John Balser. (2009) Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 16:5, pages 897-906.
Crossref
Santiago Palacios. (2009) Managing urogenital atrophy. Maturitas 63:4, pages 315-318.
Crossref
JoAnn V PinkertonDale W StovallRebecca S Kightlinger. (2009) Advances in the Treatment of Menopausal Symptoms. Women's Health 5:4, pages 361-384.
Crossref
Megan Krause, Thomas L. WheelerIIII, Thomas E. Snyder & Holly E. Richter. (2009) Local Effects of Vaginally Administered Estrogen Therapy. Journal of Pelvic Medicine and Surgery 15:3, pages 105-114.
Crossref
Rossella E. Nappi & Franco Polatti. (2009) Continuing Medical Education: The Use of Estrogen Therapy in Women's Sexual Functioning (CME). The Journal of Sexual Medicine 6:3, pages 603-616.
Crossref
Margery L. S. Gass, Shari S. Bassuk & JoAnn E. Manson. (2008) Reassessing Benefits and Risks of Hormone Therapy. American Journal of Lifestyle Medicine 3:1, pages 29-43.
Crossref
Lucia Alves Da Silva Lara, Bernardo Useche, Rui Alberto Ferriani, Rosana Maria Reis, Marcos Felipe Silva De Sá, Mauricio Mesquita Sabino De Freitas, Julio César Rosa E Silva & Ana Carolina Japur De Sá Rosa e Silva. (2009) REVIEWS: The Effects of Hypoestrogenism on the Vaginal Wall: Interference with the Normal Sexual Response. The Journal of Sexual Medicine 6:1, pages 30-39.
Crossref
Fernand Labrie, Leonello Cusan, José-Luis Gomez, Isabelle Côté, René Bérubé, Patrick Bélanger, Céline Martel & Claude Labrie. (2009) Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause 16:1, pages 30-36.
Crossref
. (2009) Urogenital Health. Journal of Obstetrics and Gynaecology Canada 31:1, pages S27-S30.
Crossref
Marit Waaseth, Kjersti Bakken, Vanessa Dumeaux, Karina S Olsen, Charlotta Rylander, Yngve Figenschau & Eiliv Lund. (2008) Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort – a cross-sectional analysis. BMC Women's Health 8:1.
Crossref
James Simon, Lila Nachtigall, Robert Gut, Eva Lang, David F. Archer & Wulf Utian. (2008) Effective Treatment of Vaginal Atrophy With an Ultra–Low-Dose Estradiol Vaginal Tablet. Obstetrics & Gynecology 112:5, pages 1053-1060.
Crossref
Joan Pitkin & Margaret Rees. (2008) Urogenital atrophy. Menopause International 14:3, pages 136-137.
Crossref
AASTA MEHTA & GLORIA BACHMANN. (2008) Vulvovaginal Complaints. Clinical Obstetrics and Gynecology 51:3, pages 549-555.
Crossref
R Malcolm. 2008. Modified-Release Drug Delivery Technology, Second Edition. Modified-Release Drug Delivery Technology, Second Edition 499 510 .
Lee P. ShulmanDavid J. PortmanWon Chan LeeSanjeev BaluAshish V. JoshiDavid CobdenQin WangChris L. Pashos. (2008) A Retrospective Managed Care Claims Data Analysis of Medication Adherence to Vaginal Estrogen Therapy: Implications for Clinical Practice. Journal of Women's Health 17:4, pages 569-578.
Crossref
T.W. Park-Simon & P. Hillemanns. (2008) Nachsorge beim MammakarzinomBreast cancer follow-up. Der Onkologe 14:5, pages 520-525.
Crossref
Mateya Trinkaus, Sheray Chin, Wendy Wolfman, Christine Simmons & Mark Clemons. (2008) Should Urogenital Atrophy in Breast Cancer Survivors Be Treated with Topical Estrogens?. The Oncologist 13:3, pages 222-231.
Crossref
Leslie R. Schover. (2008) Premature Ovarian Failure and Its Consequences: Vasomotor Symptoms, Sexuality, and Fertility. Journal of Clinical Oncology 26:5, pages 753-758.
Crossref
Karin M. E. Hahn. 2008. Breast Cancer 2nd edition. Breast Cancer 2nd edition 525 534 .
P. Stute & L. Kiesel. (2007) Lokale Östrogentherapie in der PostmenopauseLocal estrogen therapy in postmenopausal women. Gynäkologische Endokrinologie 5:3, pages 150-156.
Crossref
Helena S. Salminen, Maria E. S??f, Sven-Erik Johansson, Hans Ringertz & Lars-Erik Strender. (2007) The effect of transvaginal estradiol on bone in aged women: A randomised controlled trial. Maturitas 57:4, pages 370-381.
Crossref
Daniel F. Hayes. (2007) Follow-up of Patients with Early Breast Cancer. New England Journal of Medicine 356:24, pages 2505-2513.
Crossref
. (2007) The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women. Menopause 14:3, pages 357-369.
Crossref
Shalender Bhasin, Paul Enzlin, Andrea Coviello & Rosemary Basson. (2007) Sexual dysfunction in men and women with endocrine disorders. The Lancet 369:9561, pages 597-611.
Crossref
Rosemary Basson & Willibrord Weijmar Schultz. (2007) Sexual sequelae of general medical disorders. The Lancet 369:9559, pages 409-424.
Crossref
Alfred O. Mueck. 2007. Therapiehandbuch Gynäkologie und Geburtshilfe. Therapiehandbuch Gynäkologie und Geburtshilfe 269 289 .
Jennifer Blake. (2006) Menopause: evidence-based practice. Best Practice & Research Clinical Obstetrics & Gynaecology 20:6, pages 799-839.
Crossref
Leslie R. Schover. (2006) Is the Fault in Our Steroids or in Our Selves?. Journal of Clinical Oncology 24:22, pages 3519-3521.
Crossref
Jin-Wook Yoo & Chi H. Lee. (2006) Drug delivery systems for hormone therapy. Journal of Controlled Release 112:1, pages 1-14.
Crossref
Candace BrownGloria Bachman. (2016) Treating Urogenital Atrophy. Women's Health 1:2, pages 279-292.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.